Volitionrx (VNRX) Retained Earnings (2011 - 2025)
Volitionrx (VNRX) posted Retained Earnings of -$252.9 million for Q4 2025, down 219.12% on a QoQ basis from $212.3 million in Q3 2025, and down 65681.18% year-over-year from N/an in Q4 2024.
Volitionrx (VNRX) Retained Earnings (2011 - 2025) Analysis & Trends
Volitionrx's Retained Earnings history runs 11 years deep, the most recent figure standing at -$252.9 million for Q4 2025.
- Quarterly Retained Earnings fell 65681.18% year-over-year to -$252.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$252.9 million (down 65681.18% YoY) and the FY2025 annual result came in at -$252.9 million, down 65681.18% from the prior year.
- Retained Earnings was -$252.9 million for Q4 2025 at Volitionrx, down from $212.3 million in the prior quarter.
- Across five years, Retained Earnings topped out at $212.3 million in Q3 2025 and bottomed at -$252.9 million in Q4 2025.
- A 5-year average of $47.1 million and a median of $282252.0 in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 1865910.05% — and 2023, when it sank 75966.48%.
- Volitionrx's Retained Earnings stood at $154.7 million in 2021, then tumbled by 208.1% to -$167.3 million in 2022, then surged by 100.15% to $243940.0 in 2023, then soared by 58.08% to $385631.0 in 2024, then plunged by 65681.18% to -$252.9 million in 2025.
- Business Quant data shows VNRX's Retained Earnings at -$252.9 million in Q4 2025, $212.3 million in Q3 2025, and -$444294.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | 2.63 Bn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | - |
| 10 | Volitionrx | 92,985.39 | -1.02 Mn | - | -252.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -252.90 Mn |
| Sep 30, 2025 | 212.31 Mn |
| Jun 30, 2025 | -444,294.00 |
| Mar 31, 2025 | 206.96 Mn |
| Dec 31, 2024 | 385,631.00 |
| Sep 30, 2024 | 202.01 Mn |
| Jun 30, 2024 | 282,252.00 |
| Mar 31, 2024 | 195.00 Mn |
| Dec 31, 2023 | 243,940.00 |
| Sep 30, 2023 | 191.52 Mn |
| Jun 30, 2023 | -185.51 Mn |
| Mar 31, 2023 | 173.47 Mn |
| Dec 31, 2022 | -167.26 Mn |
| Sep 30, 2022 | 162.94 Mn |
| Jun 30, 2022 | 244,519.00 |
| Mar 31, 2022 | 30,422.00 |
| Dec 31, 2021 | 154.73 Mn |
| Sep 30, 2021 | 8,732.00 |
| Jun 30, 2021 | 29,607.00 |
| Dec 31, 2020 | -110.17 Mn |